Skip to content
Screener

Kestra Medical Technologies KMTS Total Liabilities & Equity

Total Liabilities & Equity at other companies

Abbott logo
AbbottABT
$109.22B+30.0%
Boston Scientific logo
Boston ScientificBSX
$44.35B+10.5%
Medtronic logo
MedtronicMDT
$93.03B+1.5%
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
$1.09B+13.4%
CeriBell, Inc. logo
CeriBell, Inc.CBLL
$166.35M-19.9%
Haemonetics logo
HaemoneticsHAE
$2.37B-3.9%

Other financials

Income statement

See full
Revenue$28.6M+66.2%
Gross profit$15.7M+105%
Operating income-$39.3M+18.4%
Net income-$38.8M+25.4%
EPS (diluted)-$0.67+57.3%

Balance sheet

See full
Cash & equivalents$99.7M-58.0%
Total debt$46.8M+5.6%
Total assets$358.5M+21.2%

Cash flow

See full
Operating cash flow-$18.7M+22.2%
CapEx$9.7M+30.8%
Free cash flow-$28.4M+9.7%

Valuation

See full
Market cap$1.55B+106%
Enterprise value$1.49B+151%
P/S16.3×+4.9×

Profitability

See full
Gross margin51.4%+10.9pp
Operating margin-141.6%-24.0pp
Net margin-138.4%-29.7pp
FCF margin-122.6%-26.1pp

Returns & leverage

See full
Current ratio4.4×-2.3×

Where this comes from

Reported directly by Kestra Medical Technologies in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026.

Filed
Jul 14, 2026, 5:16 PM EDT
Fiscal year
FY2026
Accession
0001193125-26-303397
Line itemApril 30, 2026April 30, 2025
Commitments and contingencies (Note 14)
Shareholders’ equity
Common Shares, $1.00 par value; 100,000,000 shares authorized as of April 30, 2026 and April 30, 2025; 58,383,924 issued and outstanding as of April 30, 2026 and 51,348,656 shares issued and outstanding as of April 30, 202558,38451,349
Additional paid-in capital853,353674,306
Accumulated other comprehensive loss(218)
Accumulated deficit(651,861)(520,249)
Total shareholders’ equity259,658205,406
Total liabilities and shareholders’ equity$358,465$295,744

Item 16. Form 10-K Summary.

FAQ

What is Kestra Medical Technologies's total liabilities & equity?
Kestra Medical Technologies (KMTS) reported total liabilities & equity of $358.47M in Q1 2026.
How has Kestra Medical Technologies's total liabilities & equity changed year-over-year?
Kestra Medical Technologies's total liabilities & equity increased by 21.2% year-over-year, from $295.74M to $358.47M.
What is the long-term trend for Kestra Medical Technologies's total liabilities & equity?
Over 2 years (2024 to 2026), Kestra Medical Technologies's total liabilities & equity has grown at a 179.3% compound annual growth rate (CAGR), from $45.95M to $358.47M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Kestra Medical Technologies's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude